{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:59:50Z","timestamp":1783691990868,"version":"3.55.0"},"reference-count":148,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is a clinicopathologic syndrome caused by fat deposition in hepatocytes. Patients with nonalcoholic steatohepatitis (NASH), an advanced form of NAFLD with severe fibrosis, are at high risk for liver-related complications, including hepatocellular carcinoma (HCC). However, the mechanism of progression from simple fat deposition to NASH is complex, and previous reports have linked NAFLD to gut microbiota, bile acids, immunity, adipokines, oxidative stress, and genetic or epigenetic factors. NASH-related liver injury involves multiple cell types, and intercellular signaling is thought to be mediated by extracellular vesicles. MicroRNAs (miRNAs) are short, noncoding RNAs that play important roles as post-transcriptional regulators of gene expression and have been implicated in the pathogenesis of various diseases. Recently, many reports have implicated microRNAs in the pathogenesis of NALFD\/NASH, suggesting that exosomal miRNAs are potential non-invasive and sensitive biomarkers and that the microRNAs involved in the mechanism of the progression of NASH may be potential therapeutic target molecules. We are interested in which miRNAs are involved in the pathogenesis of NASH and which are potential target molecules for therapy. We summarize targeted miRNAs associated with the etiology and progression of NASH and discuss each miRNA in terms of its pathophysiology, potential therapeutic applications, and efficacy as a NASH biomarker.<\/jats:p>","DOI":"10.3390\/ijms241914482","type":"journal-article","created":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T10:36:26Z","timestamp":1695551786000},"page":"14482","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["MicroRNAs and Nonalcoholic Steatohepatitis: A Review"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0760-3045","authenticated-orcid":false,"given":"Asahiro","family":"Morishita","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kita-gun 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9531-7240","authenticated-orcid":false,"given":"Kyoko","family":"Oura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kita-gun 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9975-386X","authenticated-orcid":false,"given":"Tomoko","family":"Tadokoro","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kita-gun 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kita-gun 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joji","family":"Tani","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kita-gun 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Kobara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kita-gun 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kita-gun 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Himoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kita-gun 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Masaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kita-gun 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jhep.2020.04.001","article-title":"Lytic cell death in metabolic liver disease","volume":"73","author":"Gautheron","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.3748\/wjg.v29.i32.4831","article-title":"Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments","volume":"29","author":"Petagine","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"m4747","DOI":"10.1136\/bmj.m4747","article-title":"Management of non-alcoholic fatty liver disease","volume":"372","author":"Petroni","year":"2021","journal-title":"BMJ"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Sayuti, N.H., Muhammad Nawawi, K.N., Goon, J.A., Mokhtar, N.M., Makpol, S., and Tan, J.K. (2023). Preventative and Therapeutic Effects of Astaxanthin on NAFLD. Antioxidants, 12.","DOI":"10.3390\/antiox12081552"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/jama.2020.10437","article-title":"Nonalcoholic Steatohepatitis-Reply","volume":"324","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"ref_10","first-page":"28","article-title":"Histopathology, grading and staging of nonalcoholic fatty liver disease","volume":"64","author":"Kleiner","year":"2018","journal-title":"Minerva Gastroenterol. Dietol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/nature07415","article-title":"Early origins and evolution of microRNAs and Piwi-interacting RNAs in animals","volume":"455","author":"Grimson","year":"2008","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1021\/cr300362f","article-title":"MicroRNA: Function, detection, and bioanalysis","volume":"113","author":"Dong","year":"2013","journal-title":"Chem. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3390\/jcm4121953","article-title":"MicroRNAs in Nonalcoholic Fatty Liver Disease","volume":"4","author":"Baffy","year":"2015","journal-title":"J. Clin. Med."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Goncalves, B.S., Meadows, A., Pereira, D.G., Puri, R., and Pillai, S.S. (2023). Insight into the Inter-Organ Crosstalk and Prognostic Role of Liver-Derived MicroRNAs in Metabolic Disease Progression. Biomedicines, 11.","DOI":"10.3390\/biomedicines11061597"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"101603","DOI":"10.1016\/j.molmet.2022.101603","article-title":"Obesity-induced miR-802 directly targets AMPK and promotes nonalcoholic steatohepatitis in mice","volume":"66","author":"Sun","year":"2022","journal-title":"Mol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Panella, R., Petri, A., Desai, B.N., Fagoonee, S., Cotton, C.A., Nguyen, P.K., Lundin, E.M., Wagshal, A., Wang, D.Z., and Naar, A.M. (2023). MicroRNA-22 Is a Key Regulator of Lipid and Metabolic Homeostasis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241612870"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/hep.26095","article-title":"MicroRNAs: New tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?","volume":"57","author":"Giordano","year":"2013","journal-title":"Hepatology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1196065","DOI":"10.3389\/fimmu.2023.1196065","article-title":"miR-200a attenuated oxidative stress, inflammation, and apoptosis in dextran sulfate sodium-induced colitis through activation of Nrf2","volume":"14","author":"Peng","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Zhu, S., Zhang, B., Zhu, T., Wang, D., Liu, C., Liu, Y., He, Y., Liang, W., Li, W., and Han, R. (2023). miR-128-3p inhibits intramuscular adipocytes differentiation in chickens by downregulating FDPS. BMC Genom., 24.","DOI":"10.1186\/s12864-023-09649-y"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Mesa-Diaz, N., Smith, M.T., Cardus, D.F., and Du, L. (2023). Development of Shortened miR-506-3p Mimics Exhibiting Strong Differentiation-Inducing Activity in Neuroblastoma Cells. Molecules, 28.","DOI":"10.3390\/molecules28176295"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Wan, Z., Zhang, Y., Lv, J., Yuan, Y., Guo, W., and Leng, Y. (2023). Exosomes derived from bone marrow mesenchymal stem cells regulate pyroptosis via the miR-143-3p\/myeloid differentiation factor 88 axis to ameliorate intestinal ischemia-reperfusion injury. Bioengineered, 14.","DOI":"10.1080\/21655979.2023.2253414"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1111\/liv.15581","article-title":"Increased let-7d-5p in non-alcoholic fatty liver promotes insulin resistance and is a potential blood biomarker for diagnosis","volume":"43","author":"Rey","year":"2023","journal-title":"Liver Int."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.7150\/ijbs.80760","article-title":"MiR-552-3p Regulates Multiple Fibrotic and Inflammatory genes Concurrently in Hepatic Stellate Cells Improving NASH-associated Phenotypes","volume":"19","author":"Ma","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"154944","DOI":"10.1016\/j.phymed.2023.154944","article-title":"Pure total flavonoids from citrus alleviate oxidative stress and inflammation in nonalcoholic fatty liver disease by regulating the miR-137-3p\/NOXA2\/NOX2 pathway","volume":"118","author":"Yan","year":"2023","journal-title":"Phytomedicine"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"155660","DOI":"10.1016\/j.metabol.2023.155660","article-title":"miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo lipogenesis","volume":"146","author":"Wang","year":"2023","journal-title":"Metabolism"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.cmet.2023.04.013","article-title":"Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment","volume":"35","author":"Wang","year":"2023","journal-title":"Cell Metab."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ding, Y., Zhao, H., Niu, W., Zhang, J., Zheng, X., Liu, Y., Zhang, J., Li, C., and Yu, B. (2023). M2 Macrophage-Derived Extracellular Vesicles Containing microRNA-501-3p Promote Colon Cancer Progression through the SETD7\/DNMT1\/SOCS3 Axis. Dis. Colon. Rectum.","DOI":"10.1097\/DCR.0000000000002986"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Bollati, V., Monti, P., Biganzoli, D., Marano, G., Favero, C., Iodice, S., Ferrari, L., Dioni, L., Bianchi, F., and Pesatori, A.C. (2023). Environmental and Lifestyle Cancer Risk Factors: Shaping Extracellular Vesicle OncomiRs and Paving the Path to Cancer Development. Cancers, 15.","DOI":"10.3390\/cancers15174317"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Wu, T., Tian, Q., Liu, R., Xu, K., Shi, S., Zhang, X., Gao, L., Yin, X., Xu, S., and Wang, P. (2023). Inhibitory role of bone marrow mesenchymal stem cells-derived exosome in non-small-cell lung cancer: microRNA-30b-5p, EZH2 and PI3K\/AKT pathway. J. Cell Mol. Med.","DOI":"10.1111\/jcmm.17933"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12944-023-01911-2","article-title":"Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease","volume":"22","author":"Jiang","year":"2023","journal-title":"Lipids Health Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)80213-5","article-title":"The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor","volume":"89","author":"Brown","year":"1997","journal-title":"Cell"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1194\/jlr.R800054-JLR200","article-title":"Cholesterol feedback: From Schoenheimer\u2019s bottle to Scap\u2019s MELADL","volume":"50","author":"Brown","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1534-5807(01)00119-8","article-title":"The SREBP pathway in Drosophila: Regulation by palmitate, not sterols","volume":"2","author":"Seegmiller","year":"2002","journal-title":"Dev. Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1101\/gad.1854309","article-title":"Evolutionary conservation and adaptation in the mechanism that regulates SREBP action: What a long, strange tRIP it\u2019s been","volume":"23","author":"Osborne","year":"2009","journal-title":"Genes Dev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1126\/science.1189862","article-title":"MiR-33 contributes to the regulation of cholesterol homeostasis","volume":"328","author":"Rayner","year":"2010","journal-title":"Science"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1126\/science.1189123","article-title":"MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis","volume":"328","author":"Kristo","year":"2010","journal-title":"Science"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"17321","DOI":"10.1073\/pnas.1008499107","article-title":"MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo","volume":"107","author":"Horie","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e003376","DOI":"10.1161\/JAHA.112.003376","article-title":"MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE\u2212\/\u2212 mice","volume":"1","author":"Horie","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1038\/ncomms3883","article-title":"MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice","volume":"4","author":"Horie","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1038\/srep05312","article-title":"MicroRNA-33b knock-in mice for an intron of sterol regulatory element-binding factor 1 (Srebf1) exhibit reduced HDL-C in vivo","volume":"4","author":"Horie","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2011.08.025","article-title":"The interaction of hepatic lipid and glucose metabolism in liver diseases","volume":"56","author":"Bechmann","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_43","first-page":"233","article-title":"Liver: Glucose metabolism and 18F-fluorodeoxyglucose PET findings in normal parenchyma and diseases","volume":"11","author":"Sarikaya","year":"2021","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/gut.2004.052167","article-title":"Diabetes increases the risk of hepatocellular carcinoma in the United States: A population based case control study","volume":"54","author":"Davila","year":"2005","journal-title":"Gut"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Sira, J., Zhang, X., Gao, L., Wabo, T.M.C., Li, J., Akiti, C., Zhang, W., and Sun, D. (2023). Effects of Inorganic Arsenic on Type 2 Diabetes Mellitus In Vivo: The Roles and Mechanisms of miRNAs. Biol. Trace Elem. Res., 1\u201311.","DOI":"10.1007\/s12011-023-03669-1"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.biocel.2017.01.009","article-title":"An \u2018alpha-beta\u2019 of pancreatic islet microribonucleotides","volume":"88","author":"Dalgaard","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4149\/gpb_2023019","article-title":"LncRNA XIST promotes insulin resistance in gestational diabetes mellitus via the microRNA-181b-5p\/NDRG2 axis","volume":"42","author":"Xu","year":"2023","journal-title":"Gen. Physiol. Biophys."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s11596-023-2738-1","article-title":"LncRNA HCG27 Promotes Glucose Uptake Ability of HUVECs by MiR-378a-3p\/MAPK1 Pathway","volume":"43","author":"Zhang","year":"2023","journal-title":"Curr. Med. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"44986","DOI":"10.1038\/srep44986","article-title":"Elevated miR-130a\/miR130b\/miR-152 expression reduces intracellular ATP levels in the pancreatic beta cell","volume":"7","author":"Ofori","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"110868","DOI":"10.1016\/j.diabres.2023.110868","article-title":"MicroRNA Biomarkers Target Genes and Pathways Associated with Type 2 Diabetes","volume":"203","author":"Kariuki","year":"2023","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Zhao, H., Tan, Z., Zhou, J., Wu, Y., Hu, Q., Ling, Q., Ling, J., Liu, M., Ma, J., and Zhang, D. (2023). The regulation of circRNA and lncRNAprotein binding in cardiovascular diseases: Emerging therapeutic targets. Biomed. Pharmacother., 165.","DOI":"10.1016\/j.biopha.2023.115067"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Gu, Y., Becker, M.A., Muller, L., Reuss, K., Umlauf, F., Tang, T., Menger, M.D., and Laschke, M.W. (2023). MicroRNAs in Tumor Endothelial Cells: Regulation, Function and Therapeutic Applications. Cells, 12.","DOI":"10.3390\/cells12131692"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Greco, M., Mirabelli, M., Salatino, A., Accattato, F., Aiello, V., Brunetti, F.S., Chiefari, E., Pullano, S.A., Fiorillo, A.S., and Foti, D.P. (2023). From Euglycemia to Recent Onset of Type 2 Diabetes Mellitus: A Proof-of-Concept Study on Circulating microRNA Profiling Reveals Distinct, and Early microRNA Signatures. Diagnostics, 13.","DOI":"10.3390\/diagnostics13142443"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0140-6736(15)00128-2","article-title":"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990\u20132013: A systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Collaborators","year":"2015","journal-title":"Lancet"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e141513","DOI":"10.1172\/JCI141513","article-title":"Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223-enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis","volume":"131","author":"He","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Matson, K., Macleod, A., Mehta, N., Sempek, E., and Tang, X. (2023). Impacts of MicroRNA-483 on Human Diseases. Noncoding RNA, 9.","DOI":"10.3390\/ncrna9040037"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"155657","DOI":"10.1016\/j.metabol.2023.155657","article-title":"SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis","volume":"146","author":"Shen","year":"2023","journal-title":"Metabolism"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Jankauskas, S.S., Gambardella, J., Sardu, C., Lombardi, A., and Santulli, G. (2021). Functional Role of miR-155 in the Pathogenesis of Diabetes Mellitus and Its Complications. Noncoding RNA, 7.","DOI":"10.3390\/ncrna7030039"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Dehaini, H., Awada, H., El-Yazbi, A., Zouein, F.A., Issa, K., Eid, A.A., Ibrahim, M., Badran, A., Baydoun, E., and Pintus, G. (2019). MicroRNAs as Potential Pharmaco-targets in Ischemia-Reperfusion Injury Compounded by Diabetes. Cells, 8.","DOI":"10.3390\/cells8020152"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/bjc.2014.587","article-title":"MiR-23a\/-24-induced gene silencing results in mesothelial cell integration of pancreatic cancer","volume":"112","author":"Listing","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: Global epidemiology and pathogenesis","volume":"15","author":"Bluher","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Nazari, M., Jalili, M., and As\u2019habi, A. (2023). Conjugated linoleic acid and L-carnitine combination effects on obesity-related miRNAs in diet-induced obese rats. Obes. Res. Clin. Pract.","DOI":"10.1016\/j.orcp.2023.08.004"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Matveev, G.A., Khromova, N.V., Zasypkin, G.G., Kononova, Y.A., Vasilyeva, E.Y., Babenko, A.Y., and Shlyakhto, E.V. (2023). Tissue and Circulating MicroRNAs 378 and 142 as Biomarkers of Obesity and Its Treatment Response. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241713426"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.celrep.2018.01.074","article-title":"Genetic Ablation of miR-33 Increases Food Intake, Enhances Adipose Tissue Expansion, and Promotes Obesity and Insulin Resistance","volume":"22","author":"Price","year":"2018","journal-title":"Cell Rep."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41580-021-00354-w","article-title":"MicroRNA-mediated regulation of glucose and lipid metabolism","volume":"22","author":"Agbu","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.imlet.2020.03.003","article-title":"MiR-149 attenuates endoplasmic reticulum stress-induced inflammation and apoptosis in nonalcoholic fatty liver disease by negatively targeting ATF6 pathway","volume":"222","author":"Chen","year":"2020","journal-title":"Immunol. Lett."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/rej.2022.0004","article-title":"Different Expression of Micro-RNA in the Subcutaneous and Visceral Adipose Tissue of Obese Subjects","volume":"25","author":"Lacedonia","year":"2022","journal-title":"Rejuvenation Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"11909","DOI":"10.1038\/srep11909","article-title":"miR-125a-3p and miR-483-5p promote adipogenesis via suppressing the RhoA\/ROCK1\/ERK1\/2 pathway in multiple symmetric lipomatosis","volume":"5","author":"Chen","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Ortega, R., Liu, B., and Persaud, S.J. (2023). Effects of miR-33 Deficiency on Metabolic and Cardiovascular Diseases: Implications for Therapeutic Intervention. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241310777"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13075-016-0929-x","article-title":"MicroRNAs in fibrosis: Opportunities and challenges","volume":"18","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3748\/wjg.v26.i11.1113","article-title":"Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis","volume":"26","author":"Iacob","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"7325","DOI":"10.18632\/oncotarget.2621","article-title":"microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K\/AKT pathway","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_75","first-page":"1919","article-title":"Plasma microRNA: A novel non-invasive biomarker for HBV-associated liver fibrosis staging","volume":"17","author":"Wang","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"34935","DOI":"10.1038\/srep34935","article-title":"MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C","volume":"6","author":"Appourchaux","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.23922","article-title":"Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis","volume":"53","author":"Roderburg","year":"2011","journal-title":"Hepatology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.19082\/1804","article-title":"Circulating miRNAs as Predictor Markers for Activation of Hepatic Stellate Cells and Progression of HCV-Induced Liver Fibrosis","volume":"8","author":"Nagy","year":"2016","journal-title":"Electron. Physician"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Cermelli, S., Ruggieri, A., Marrero, J.A., Ioannou, G.N., and Beretta, L. (2011). Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023937"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s10020-021-00364-6","article-title":"MiR-100 overexpression attenuates high fat diet induced weight gain, liver steatosis, hypertriglyceridemia and development of metabolic syndrome in mice","volume":"27","author":"Smolka","year":"2021","journal-title":"Mol. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3748\/wjg.v21.i2.511","article-title":"miRNA-103: Molecular link between insulin resistance and nonalcoholic fatty liver disease","volume":"21","author":"Xu","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000519995","article-title":"Dynamics of Circulating miR-122 Predict Liver Cancer and Mortality in Japanese Patients with Histopathologically Confirmed NAFLD and Severe Fibrosis Stage","volume":"100","author":"Akuta","year":"2022","journal-title":"Oncology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3892\/mmr.2021.12137","article-title":"Circulating microRNA-135a-3p in serum extracellular vesicles as a potential biological marker of non-alcoholic fatty liver disease","volume":"24","author":"Jiang","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"18856","DOI":"10.1038\/s41598-019-55076-z","article-title":"Association of circulating miR-20a, miR-27a, and miR-126 with non-alcoholic fatty liver disease in general population","volume":"9","author":"Ando","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1055\/a-1587-9211","article-title":"Clinical Value and Role of miR-129-5p in Non-Alcoholic Fatty Liver Disease","volume":"53","author":"Wang","year":"2021","journal-title":"Horm. Metab. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.7754\/Clin.Lab.2019.190335","article-title":"Decreased Serum miR-1296 may Serve as an Early Biomarker for the Diagnosis of Non-Alcoholic Fatty Liver Disease","volume":"65","author":"Yu","year":"2019","journal-title":"Clin. Lab."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1159\/000447917","article-title":"Decreased MiR-155 Level in the Peripheral Blood of Non-Alcoholic Fatty Liver Disease Patients may Serve as a Biomarker and may Influence LXR Activity","volume":"39","author":"Wang","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.lfs.2018.07.029","article-title":"Plasma miR-17, miR-20a, miR-20b and miR-122 as potential biomarkers for diagnosis of NAFLD in type 2 diabetes mellitus patients","volume":"208","author":"Ye","year":"2018","journal-title":"Life Sci."},{"key":"ref_89","first-page":"377","article-title":"Potential biomarkers in NASH-induced liver cirrhosis with hepatocellular carcinoma: A preliminary work on roles of exosomal miR-182, miR-301a, and miR-373","volume":"42","author":"Mokhtar","year":"2020","journal-title":"Malays. J. Pathol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.31050","article-title":"Lipotoxic Hepatocyte-Derived Exosomal MicroRNA 192-5p Activates Macrophages through Rictor\/Akt\/Forkhead Box Transcription Factor O1 Signaling in Nonalcoholic Fatty Liver Disease","volume":"72","author":"Liu","year":"2020","journal-title":"Hepatology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"100409","DOI":"10.1016\/j.jhepr.2021.100409","article-title":"Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance","volume":"4","author":"Johnson","year":"2022","journal-title":"JHEP Rep."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Li, Y., Jiang, H.T., Han, L.B., Xiao, L., and Gan, J.H. (2020). MiR-195 regulates CD40 to maintain Th17\/Treg balance in rats with non-alcoholic fatty liver disease. Biomed. Pharmacother., 124.","DOI":"10.1016\/j.biopha.2020.109930"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Wang, X., Ma, Y., Yang, L.Y., and Zhao, D. (2020). MicroRNA-20a-5p Ameliorates Non-alcoholic Fatty Liver Disease via Inhibiting the Expression of CD36. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.596329"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3892\/ijmm.2015.2076","article-title":"miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR","volume":"35","author":"Sun","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3892\/mmr.2021.12463","article-title":"PPARgamma attenuates hepatic inflammation and oxidative stress of non-alcoholic steatohepatitis via modulating the miR-21-5p\/SFRP5 pathway","volume":"24","author":"Zhang","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/2211536607666180531093302","article-title":"Serum miR-29a and miR-122 as Potential Biomarkers for Non-Alcoholic Fatty Liver Disease (NAFLD)","volume":"7","author":"Jampoka","year":"2018","journal-title":"Microrna"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/liv.14067","article-title":"MicroRNA-30b regulates insulin sensitivity by targeting SERCA2b in non-alcoholic fatty liver disease","volume":"39","author":"Dai","year":"2019","journal-title":"Liver Int."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Erhartova, D., Cahova, M., Dankova, H., Heczkova, M., Mikova, I., Sticova, E., Spicak, J., Seda, O., and Trunecka, P. (2019). Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0224820"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1038\/srep13729","article-title":"Effect of miR-34a in regulating steatosis by targeting PPARalpha expression in nonalcoholic fatty liver disease","volume":"5","author":"Ding","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Xin, S., Zhan, Q., Chen, X., Xu, J., and Yu, Y. (2020). Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: A systematic review and meta-analysis. BMC Gastroenterol., 20.","DOI":"10.1186\/s12876-020-01334-8"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Gerhard, G.S., Hanson, A., Wilhelmsen, D., Piras, I.S., Still, C.D., Chu, X., Petrick, A.T., and DiStefano, J.K. (2019). AEBP1 expression increases with severity of fibrosis in NASH and is regulated by glucose, palmitate, and miR-372-3p. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0219764"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/1440-1681.12940","article-title":"Down-regulation of microRNA-375 regulates adipokines and inhibits inflammatory cytokines by targeting AdipoR2 in non-alcoholic fatty liver disease","volume":"45","author":"Lei","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Okamoto, K., Koda, M., Okamoto, T., Onoyama, T., Miyoshi, K., Kishina, M., Matono, T., Kato, J., Tokunaga, S., and Sugihara, T. (2020). Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0219412"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2013.05.021","article-title":"Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver","volume":"424","author":"Yamada","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"102258","DOI":"10.1016\/j.dsx.2021.102258","article-title":"Serum microRNA-486-5p expression in obese Egyptian children and its possible association with fatty liver","volume":"15","author":"Behiry","year":"2021","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.2147\/DMSO.S231321","article-title":"The Circulating Micro-RNAs (-122, -34a and -99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases","volume":"12","author":"Hendy","year":"2019","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Hayes, C.N., and Chayama, K. (2016). MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17030280"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Markovic, J., Sharma, A.D., and Balakrishnan, A. (2020). MicroRNA-221: A Fine Tuner and Potential Biomarker of Chronic Liver Injury. Cells, 9.","DOI":"10.3390\/cells9081767"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41419-018-0752-1","article-title":"MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression","volume":"9","author":"Ma","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3727\/105221616X693891","article-title":"Knockdown of miR-23, miR-27, and miR-24 Alters Fetal Liver Development and Blocks Fibrosis in Mice","volume":"17","author":"Rogler","year":"2017","journal-title":"Gene Expr."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Lai, C.Y., Yeh, K.Y., Lin, C.Y., Hsieh, Y.W., Lai, H.H., Chen, J.R., Hsu, C.C., and Her, G.M. (2021). MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K\/AKT, TGF-beta, and STAT3 Signaling. Cancers, 13.","DOI":"10.3390\/cancers13050940"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Yang, Y.L., Kuo, H.C., Wang, F.S., and Huang, Y.H. (2019). MicroRNA-29a Disrupts DNMT3b to Ameliorate Diet-Induced Non-Alcoholic Steatohepatitis in Mice. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061499"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1053\/j.gastro.2020.05.056","article-title":"Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122","volume":"159","author":"Chai","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"563265","DOI":"10.3389\/fgene.2020.563265","article-title":"Downregulated microRNA-129-5p by Long Non-coding RNA NEAT1 Upregulates PEG3 Expression to Aggravate Non-alcoholic Steatohepatitis","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Genet."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1111\/jcmm.16376","article-title":"Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN\/PI3K\/AKT pathway","volume":"25","author":"Riaz","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Benito-Vicente, A., Uribe, K.B., Rotllan, N., Ramirez, C.M., Jebari-Benslaiman, S., Goedeke, L., Canfran-Duque, A., Galicia-Garcia, U., Saenz De Urturi, D., and Aspichueta, P. (2020). miR-27b Modulates Insulin Signaling in Hepatocytes by Regulating Insulin Receptor Expression. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228675"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1111\/jcmm.13278","article-title":"MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy","volume":"21","author":"Chen","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1038\/mt.2016.127","article-title":"MiR-29a Assists in Preventing the Activation of Human Stellate Cells and Promotes Recovery from Liver Fibrosis in Mice","volume":"24","author":"Matsumoto","year":"2016","journal-title":"Mol. Ther."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Lin, H.Y., Wang, F.S., Yang, Y.L., and Huang, Y.H. (2019). MicroRNA-29a Suppresses CD36 to Ameliorate High Fat Diet-Induced Steatohepatitis and Liver Fibrosis in Mice. Cells, 8.","DOI":"10.3390\/cells8101298"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"212","DOI":"10.7150\/ijms.29930","article-title":"MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation","volume":"16","author":"Huang","year":"2019","journal-title":"Int. J. Med. Sci."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/cbin.11022","article-title":"MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-beta1\/Smad3 pathway in hepatic stellate cells","volume":"42","author":"Feili","year":"2018","journal-title":"Cell Biol. Int."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1172\/JCI122258","article-title":"Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223","volume":"129","author":"Calvente","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.omtn.2019.05.001","article-title":"miR-455-3p Alleviates Hepatic Stellate Cell Activation and Liver Fibrosis by Suppressing HSF1 Expression","volume":"16","author":"Wei","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.aohep.2019.06.016","article-title":"miR-125b acts as anti-fibrotic therapeutic target through regulating Gli3 in vivo and in vitro","volume":"18","author":"Hu","year":"2019","journal-title":"Ann. Hepatol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"10993","DOI":"10.1038\/ncomms10993","article-title":"MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression","volume":"7","author":"Hyun","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_126","first-page":"425","article-title":"Downregulation of miR-152 contributes to the progression of liver fibrosis via targeting Gli3 in vivo and in vitro","volume":"18","author":"Li","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"G491","DOI":"10.1152\/ajpgi.00140.2015","article-title":"Suppression of fibrogenic signaling in hepatic stellate cells by Twist1-dependent microRNA-214 expression: Role of exosomes in horizontal transfer of Twist1","volume":"309","author":"Chen","year":"2015","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/j.ajpath.2016.07.011","article-title":"Fibrogenic Signaling Is Suppressed in Hepatic Stellate Cells through Targeting of Connective Tissue Growth Factor (CCN2) by Cellular or Exosomal MicroRNA-199a-5p","volume":"186","author":"Chen","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jcmgh.2015.07.007","article-title":"Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cell via microRNAs targeting PPAR-gamma","volume":"1","author":"Povero","year":"2015","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/acer.13116","article-title":"Processing of miR17-92 Cluster in Hepatic Stellate Cells Promotes Hepatic Fibrogenesis during Alcohol-Induced Injury","volume":"40","author":"Feilen","year":"2016","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bbrc.2015.09.166","article-title":"Human fibrocyte-derived exosomes accelerate wound healing in genetically diabetic mice","volume":"467","author":"Geiger","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1111\/jcmm.13208","article-title":"MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis","volume":"21","author":"Lou","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1461505","DOI":"10.1080\/20013078.2018.1461505","article-title":"Therapeutic effects of serum extracellular vesicles in liver fibrosis","volume":"7","author":"Chen","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/hep4.1080","article-title":"Use of Mac-2 binding protein as a biomarker for nonalcoholic fatty liver disease diagnosis","volume":"1","author":"Kamada","year":"2017","journal-title":"Hepatol. Commun."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"107427","DOI":"10.1016\/j.isci.2023.107427","article-title":"Circulating microRNAs improve bacterial infection diagnosis and overall survival prediction in acute decompensation of liver cirrhosis","volume":"26","author":"Chouik","year":"2023","journal-title":"iScience"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.omtn.2023.07.012","article-title":"Therapeutic inhibition of miR-155 attenuates liver fibrosis via STAT3 signaling","volume":"33","author":"Bala","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Wang, Q., Long, Z., Zhu, F., Li, H., Xiang, Z., Liang, H., Wu, Y., Dai, X., and Zhu, Z. (2023). Integrated analysis of lncRNA\/circRNA-miRNA-mRNA in the proliferative phase of liver regeneration in mice with liver fibrosis. BMC Genom., 24.","DOI":"10.1186\/s12864-023-09478-z"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/qjmed\/hcp158","article-title":"Pathogenesis of non-alcoholic fatty liver disease","volume":"103","author":"Dowman","year":"2010","journal-title":"QJM"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1756284818815184","DOI":"10.1177\/1756284818815184","article-title":"Function and therapeutic advances of chemokine and its receptor in nonalcoholic fatty liver disease","volume":"11","author":"Chen","year":"2018","journal-title":"Therap. Adv. Gastroenterol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.3390\/ijms15058591","article-title":"Evolving concepts in the pathogenesis of NASH: Beyond steatosis and inflammation","volume":"15","author":"Peverill","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.3748\/wjg.v24.i36.4104","article-title":"Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease","volume":"24","author":"Torres","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3892\/ijmm.2015.2092","article-title":"MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis","volume":"35","author":"Katsura","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc1408","article-title":"Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms","volume":"4","author":"Calle","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","article-title":"Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression","volume":"140","author":"Park","year":"2010","journal-title":"Cell"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2014.07.001","article-title":"ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development","volume":"26","author":"Nakagawa","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/2211536612666230330083146","article-title":"Circulating MicroRNAs: Diagnostic Value as Biomarkers in the Detection of Non-alcoholic Fatty Liver Diseases and Hepatocellular Carcinoma","volume":"12","author":"Rana","year":"2023","journal-title":"Microrna"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1053\/j.gastro.2015.09.042","article-title":"Regulation of Liver Metabolism by Autophagy","volume":"150","author":"Cuervo","year":"2016","journal-title":"Gastroenterology"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/19\/14482\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:56:44Z","timestamp":1760129804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/19\/14482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,23]]},"references-count":148,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["ijms241914482"],"URL":"https:\/\/doi.org\/10.3390\/ijms241914482","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,23]]}}}